Showing results (11-20 of 212) with videos related to
Sort By:
Pageof 22
Cancer Medicine|September 18, 2015
B7-H3 protein expression in acute myeloid leukemiaThomas Guery, Christophe Roumier, Celine Berthon, et al.Haematologica|January 12, 2005
Factors predicting molecular and cytogenetic response in chronic myeloid leukemia patients treated with imatinibCatherine Roche-Lestienne, Stéphane Darré, Jean-Luc Laï, et al.La Tunisie Medicale|August 31, 2016
Minimal Residual Disease assessment of IDH1/2 mutations in Acute Myeloid Leukemia by LNA-RQ-PCREmna Abdelhamid, Sawsen Besbes, Aline Renneville, et al.Cancer Genetics and Cytogenetics|April 7, 2004
Chromosomal insertion involving MLL in childhood acute myeloblastic leukemia (M4)Lucie Lafay-Cousin, Valérie Soenen, Françoise Mazingue, et al.Leukemia & Lymphoma|July 16, 2005
Therapy-related acute lymphoblastic leukemia with MLL rearrangement following treatment of Burkitt's leukemiaFrederic Millot, Francoise Brizard, Nathalie Sorel, et al.Blood|May 3, 2002
Unlike AML1, CBFbeta gene is not deregulated by point mutations in acute myeloid leukemia and in myelodysplastic syndromesHugues Leroy, Christophe Roumier, Nathalie Grardel-Duflos, et al.Expert Opinion on Therapeutic Targets|April 28, 2021
Targeting RUNX1 in acute myeloid leukemia: preclinical innovations and therapeutic implicationsFanny Gonzales, Adeline Barthélémy, Pauline Peyrouze, et al.Clinical Biochemistry|June 11, 2014
Calibration of BCR-ABL1 mRNA quantification methods using genetic reference materials is a valid strategy to report results on the international scaleCarole Mauté, Olivier Nibourel, Delphine Réa, et al.Cancer Medicine|February 12, 2019
CD9 in acute myeloid leukemia: Prognostic role and usefulness to target leukemic stem cellsLucas Touzet, Florent Dumezy, Christophe Roumier, et al.Phytochemistry|November 11, 2008
Activity of elaeochytrin A from Ferula elaeochytris on leukemia cell linesRacha Alkhatib, Thierry Hennebelle, Sami Joha, et al.Pageof 22